Evidence map›Paper›PMID 11160152›Full record

ArticleThe Journal of clinical investigation2001

Leukemia inhibitory factor inhibits HIV-1 replication and is upregulated in placentae from nontransmitting women.

B K Patterson, H Behbahani, W J Kabat, Y Sullivan, M R O'Gorman, A Landay, Z Flener, N Khan, R Yogev, J Andersson

Open access · bronzeAbstract readCommentComparative Study
In one paragraph

Article in The Journal of clinical investigation, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 86 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Leukemia inhibitory factor, a double-edged sword with therapeutic implications in human diseases.Molecular therapy : the journal of the American Society of Gene Therapy · 2023
    Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Immunology of pediatric HIV infection.Immunological reviews · 2013
    Review
  14. Role of the placenta in adverse perinatal outcomes among HIV-1 seropositive women.Journal of Nippon Medical School = Nippon Ika Daigaku zasshi · 2013
    Review
  15. Study of HIV-1 transmission across cervical mucosa to tonsil tissue cells using an organ culture.American journal of reproductive immunology (New York, N.Y. : 1989) · 2013
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

B K PattersonDepartment of Pediatrics, Division of Infectious Diseases, Children's Memorial Hospital/Northwestern University Medical School, 2300 Children's Plaza #51, Chicago, Illinois 60614, USA. bpatterson@childrensmemorial.org
H Behbahani
W J Kabat
Y Sullivan
M R O'Gorman
A Landay
Z Flener
N Khan
R Yogev
J Andersson
Lurie Children's Hospital · USKarolinska University Hospital · SERush University Medical Center · USComer Children's Hospital · USNorthwestern Memorial Hospital · USNorthwestern University · US

Funding

HIV 1 SUSCEPTIBILITY FACTORS IN THE FEMALE GENITAL TRACTR01AI047065 · NIAID · STANFORD UNIVERSITY · PI PATTERSON, BRUCE K · 2000 to 2003
$1.1M
NIAID NIH HHS R01 AI047065
6 · The paper itself

Abstract

The placenta may play a critical role in inhibiting vertical transmission of HIV-1. Here we demonstrate that leukemia inhibitory factor (LIF) is a potent endogenous HIV-1-suppressive factor produced locally in placentae. In vitro, LIF exerted a potent, gp130-LIFRbeta-dependent, HIV coreceptor-independent inhibition of HIV-1 replication with IC50 values between 0.1 pg/ml and 0.7 pg/ml, depending on the HIV-1 isolate. LIF also inhibited HIV-1 in placenta and thymus tissues grown in ex vivo organ culture. The level of LIF mRNA and the incidence of LIF protein-expressing cells were significantly greater in placentae from HIV-1-infected women who did not transmit HIV-1 to their fetuses compared with women who transmitted the infection, but they were not significantly different from placentae of uninfected mothers. These findings demonstrate a novel pathway for endogenous HIV suppression that may prove to be an effective immune therapy for HIV infection.

Indexed as

Interleukin-6AdultCell DivisionCells, CulturedContactinsDNA, ViralFemaleGene ExpressionGrowth InhibitorsHIV-1HIV InfectionsHumansIn Vitro TechniquesLeukemia Inhibitory FactorLeukemia Inhibitory Factor Receptor alpha SubunitLymphokinesContactinsDNA, ViralGrowth InhibitorsInterleukin-6Leukemia Inhibitory FactorLeukemia Inhibitory Factor Receptor alpha SubunitLIF protein, humanLIFR protein, humanLymphokinesNeural Cell Adhesion MoleculesReceptors, CytokineReceptors, OSM-LIFRNA, Messenger

Identifiers

PMID11160152
PMCPMC199198
OpenAlexW2115558627

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.